NASDAQ
No price data available for this timeframe.
Amedisys, Inc. (AMED) reported revenue of $2.35B and net income of $43.23M for FY 2024. The gross profit margin is 43.3% with a net profit margin of 1.8%.
Financial data for AMED
5.01% YoY
543.53% YoY
540.00% YoY
Annual Income Statement for AMED
| Item | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | $2B | $2B | $2B | $2B | $2B |
| Cost of Revenue | $1B | $1B | $1B | $1B | $1B |
| Gross Profit | $1B | $991M | $963M | $981M | $886M |
| Operating Expenses | $923M | $834M | $779M | $729M | $663M |
| Operating Income | $95M | $156M | $181M | $252M | $219M |
| Net Income | $43M | -$10M | $119M | $209M | $184M |
| EPS | $1.32 | $-0.30 | $3.65 | $6.41 | $5.64 |
| EBITDA | $73M | $217M | $207M | $321M | $251M |